Research
10.1.2022

Comparison of BiomeOne and PD-L1 expression tests as a predictor for response to immune checkpoint inhibitors (ICI) in patients with non-small cell lung cancer (NSCLC)

ready to TALK MICROBIOME?
Reach out to our team with any questions about BiomeDx. We're here to support your understanding of our platform and services.
Arrow right icon
z
z
z
z
i
i
z
z
Let’s build the future of
preventive health.
Bring AI-powered microbiome insights to your customers.
Join our global network of laboratories, clinics, and research centres.